Morgan Stanley analyst Robert Davies upgraded Smith & Nephew to Overweight from Equal Weight with a price target of 1,364 GBp, up from 1,251 GBp. The stock screens well within a sector context, with a combination of self help opportunities and an attractive valuation, the analyst tells investors in a research note. The firm says slective procedure volume recovery is a tailwind for Smith & Nephew.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNN:
- Smith & Nephew downgraded to Underweight from Overweight at Barclays
- Smith & Nephew price target raised to 1,600 GBp from 1,500 GBp at RBC Capital
- Smith & Nephew re-initiated with an Outperform at Bernstein
- Smith & Nephew upgraded to Buy from Hold at Liberum
- Smith & Nephew price target raised to 1,000 GBp from 970 GBp at UBS